Summit X LLC’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-395
| Closed | -$216K | – | 233 |
|
|
2024
Q2 | $216K | Buy |
+395
| New | +$216K | 0.05% | 224 |
|
|
2023
Q3 | – | Sell |
-2,637
| Closed | -$1.38M | – | 267 |
|
|
2023
Q2 | $1.38M | Buy |
2,637
+98
| +4% | +$51.2K | 0.33% | 58 |
|
|
2023
Q1 | $1.46M | Sell |
2,539
-154
| -6% | -$88.8K | 0.38% | 51 |
|
|
2022
Q4 | $1.46M | Sell |
2,693
-71
| -3% | -$38.6K | 0.42% | 53 |
|
|
2022
Q3 | $1.4M | Buy |
2,764
+71
| +3% | +$36K | 0.41% | 58 |
|
|
2022
Q2 | $1.46M | Sell |
2,693
-69
| -2% | -$37.5K | 0.42% | 53 |
|
|
2022
Q1 | $1.63M | Sell |
2,762
-50
| -2% | -$29.5K | 0.4% | 52 |
|
|
2021
Q4 | $1.88M | Sell |
2,812
-10
| -0.4% | -$6.67K | 0.44% | 50 |
|
|
2021
Q3 | $1.61M | Sell |
2,822
-5
| -0.2% | -$2.85K | 0.4% | 56 |
|
|
2021
Q2 | $1.43M | Sell |
2,827
-14
| -0.5% | -$7.07K | 0.36% | 64 |
|
|
2021
Q1 | $1.3M | Sell |
2,841
-76
| -3% | -$34.7K | 0.36% | 66 |
|
|
2020
Q4 | $1.36M | Sell |
2,917
-140
| -5% | -$65.3K | 0.4% | 58 |
|
|
2020
Q3 | $21.6K | Buy |
3,057
+57
| +2% | +$403 | 0.35% | 43 |
|
|
2020
Q2 | $1.09M | Buy |
3,000
+70
| +2% | +$25.4K | 0.4% | 65 |
|
|
2020
Q1 | $832K | Sell |
2,930
-15
| -0.5% | -$4.26K | 0.39% | 68 |
|
|
2019
Q4 | $953K | Sell |
2,945
-230
| -7% | -$74.4K | 0.35% | 70 |
|
|
2019
Q3 | $922K | Sell |
3,175
-5
| -0.2% | -$1.45K | 0.37% | 73 |
|
|
2019
Q2 | $940K | Buy |
3,180
+30
| +1% | +$8.87K | 0.38% | 67 |
|
|
2019
Q1 | $856K | Buy |
3,150
+265
| +9% | +$72K | 0.37% | 71 |
|
|
2018
Q4 | $640K | Buy |
2,885
+10
| +0.3% | +$2.22K | 0.37% | 77 |
|
|
2018
Q3 | $704K | Sell |
2,875
-20
| -0.7% | -$4.9K | 0.35% | 68 |
|
|
2018
Q2 | $591K | Buy |
2,895
+40
| +1% | +$8.17K | 0.33% | 78 |
|
|
2018
Q1 | $580K | Buy |
2,855
+75
| +3% | +$15.2K | 0.35% | 79 |
|
|
2017
Q4 | $522K | Buy |
2,780
+100
| +4% | +$18.8K | 0.33% | 85 |
|
|
2017
Q3 | $502K | Buy |
2,680
+105
| +4% | +$19.7K | 0.33% | 79 |
|
|
2017
Q2 | $443K | Buy |
+2,575
| New | +$443K | 0.32% | 98 |
|